Details for New Drug Application (NDA): 040430
✉ Email this page to a colleague
The generic ingredient in ETHOSUXIMIDE is ethosuximide. There is one drug master file entry for this compound. Nine suppliers are listed for this compound. Additional details are available on the ethosuximide profile page.
Summary for 040430
Tradename: | ETHOSUXIMIDE |
Applicant: | Bionpharma |
Ingredient: | ethosuximide |
Patents: | 0 |
Pharmacology for NDA: 040430
Physiological Effect | Decreased Central Nervous System Disorganized Electrical Activity |
Medical Subject Heading (MeSH) Categories for 040430
Suppliers and Packaging for NDA: 040430
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ETHOSUXIMIDE | ethosuximide | CAPSULE;ORAL | 040430 | ANDA | Bryant Ranch Prepack | 63629-8005 | 63629-8005-1 | 90 CAPSULE, LIQUID FILLED in 1 BOTTLE (63629-8005-1) |
ETHOSUXIMIDE | ethosuximide | CAPSULE;ORAL | 040430 | ANDA | Bionpharma Inc. | 69452-152 | 69452-152-20 | 100 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC (69452-152-20) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 250MG | ||||
Approval Date: | Oct 28, 2002 | TE: | AB | RLD: | No |
Complete Access Available with Subscription